Johns Hopkins researchers innovate treatment for superior canal dehiscence, help develop nanoparticles to treat hearing loss, and more.
In 2021, the Johns Hopkins Department of Otolaryngology–Head and Neck Surgery was awarded more NIH funding than any peer department in the country and garnered more citations of its research than ever before.
The department launched a new center for facial schwannomas, achieved national recognition for the treatment of skull base tumors, and introduced cutting-edge treatments for small papillary thyroid cancer and recurrent respiratory papillomatosis (RRP).
A Johns Hopkins Medicine study of about 50 people with Alzheimer’s disease has added to evidence that damage to the inner ear system that controls balance is a major factor in patients’ well-documented higher risk of falling.
Johns Hopkins is one of few medical centers to offer the Maddern procedure, through which scar tissue from the condition can be permanently removed to restore breathing.
Tailored thyroid care for individuals is possible at Johns Hopkins — as its head and neck surgeons offer the full spectrum of approaches along with high expertise in each modality. It is among the few centers globally to do so.
A multidisciplinary team, including rhinologist Jean Kim, uncovers how a massive protein complex found in the nose and which causes chronic inflammation in sinus tissue and nasal polyps is formed.
This investigational therapy may represent a new option beyond behavioral modification and neuromodulators. Johns Hopkins is currently the only center in the mid-Atlantic region offering the approach.
Vaccinations against human papillomavirus (HPV), a major cause of throat and back of mouth cancers, are expected to yield significant reductions in the rates of these cancers in the U.S., but will not do so until after 2045, according ...
Based on data compiled by the federal government, Johns Hopkins Medicine researchers have determined there is no evidence so far that people receiving a COVID-19 vaccination are at a higher risk of developing sudden hearing loss than people ...
Johns Hopkins Medicine researchers have studied one of the known causes of anosmia — long-term exposure to air pollution — to better understand how it can rob someone of the ability to smell and taste.
In the midst of responding to the pandemic, faculty and staff members innovated in the area of patient care.
The department received the highest amount of NIH funding across all similar departments in the country in 2020 — totaling more than $15 million — and the number of papers published by faculty increased by 27% in 2020 compared with 2019.
Johns Hopkins Medicine researchers have shown that a device implanted in the inner ear can facilitate walking, relieve dizziness and improve quality of life for the 1.8 million adults worldwide with bilateral vestibular hypofunction (BVH), ...
A wide breadth of behaviors surrounding oral sex may affect the risk of oral HPV infection and of a virus-associated head and neck cancer that can be spread through this route, a new study led by researchers at the Johns Hopkins Kimmel Cancer Center suggests.
Using artificial intelligence and machine learning, Johns Hopkins physicians are developing a tool for more sensitive and specific diagnosis.
As one of the most comprehensive programs for swallowing disorders in the mid-Atlantic, laryngologist Shumon Dhar and his colleagues offer an array of diagnostic and therapeutic options.
Using a thermoplastic polymer and the patient’s rib cartilage and vascularized fascia, Johns Hopkins facial plastic and reconstructive surgeon Kofi Boahene and team successfully replaced the patient’s trachea.
A team of otolaryngologists and pathologists at Johns Hopkins Medicine has confirmed that SARS-CoV-2, the novel coronavirus behind the current COVID-19 pandemic, can colonize the middle ear and mastoid region of the head behind the ear.
For certain patients, an implanted device delivered via minimally invasive surgery offers an alternative to continuous positive airway pressure.
A new Johns Hopkins study suggests that genetic sequencing could hold key to identifying patients who would benefit from treatments.
New center brings together experts that focus on these unique tumors.
There’s a stem cell in your nose that can switch identities to potentially serve as a protective mechanism.
Delayed diagnosis of newborn hearing loss can dramatically impact speech and language development.
ENTAA Care, a member of Johns Hopkins Regional Physicians, serves patients throughout Maryland.
At the Johns Hopkins Listening Center, a team of dedicated auditory rehabilitation therapists helps patients train their brains to interpret the signals delivered by cochlear implants.
Opens in stages beginning May 28.
One anticipated outcome of the new findings is that by taking a biopsy and sequencing the DNA of one of these tumors, clinicians could look for the degree of MSI intensity when forming a treatment plan for patients.
Headway Winter 2019
HeadWay April 2018
HeadLines June 26, 2017
HeadLines Spring 2017
HeadLine December 2, 2016
HeadLine December 2, 2016
HeadWay November 22, 2016
HeadWay April 8, 2016
HeadWay November 23, 2015
Insight May 2015
HeadWay April 6, 2015
HeadWay June 18, 2013
HeadWay June 18, 2013